Despite what the name suggests, Polyendocrine Metabolic Ovarian Syndrome isn’t just about ovaries—or cysts, for that matter. In fact, many people diagnosed with PMOS don’t have any ovarian cysts at all. Confusing? You’re not alone. The name dates back to how the condition was first described, but science has come a long way since then. Today, we understand that PCOS is really a complex hormonal and metabolic condition that affects far more than reproductive health.
At its core, PMOS is about hormonal imbalance. When key hormones like insulin, androgens (like testosterone), and others are out of sync, they can create a domino effect throughout the body. This hormonal miscommunication can lead to irregular periods, acne, weight changes, hair loss or excess hair growth, difficulty with ovulation or fertility—and that’s just the shortlist. But here’s the thing: PMOS doesn’t follow a single pattern. Some women experience textbook symptoms. Others don’t fit the mold at all. That’s part of what makes PMOS so challenging—and why understanding your unique experience matters.
So, how can the PMOS Association help?
We’re here to offer more than definitions. We’re here to offer direction. Whether you’re newly diagnosed, still searching for answers, or years into your journey and feeling stuck, we’re committed to helping you make sense of PMOS—and make progress.
Here’s what you’ll find at PMOSA:
✅ Reliable, science-backed information about what PMOS is (and isn’t)
💬 Supportive communities of people who understand exactly what you’re going through
🧬 Resources for navigating fertility, metabolic health, nutrition, and more
🧠 Education for providers who want to better support their PMOS patients
🙋♀️ Advocacy to make sure PMOS is recognized, researched, and respected
No fluff. No fad cures. Just real support, grounded in evidence and compassion.
At PMOSA, we believe every person with PCOS deserves to be informed, empowered, and heard. Wherever you are in your journey, we’re honored to walk with you.
pcos: Latest results from PubMed
There is a growing prevalence of polycystic ovary syndrome (PCOS) among young women who work and the level of awareness and the way women implement healthy lifestyle practices in their respective jobs is still not high enough. This study looked at how aware female IT employees in Nagpur were of PCOS and their healthy lifestyle practices regarding the syndrome using a cross-sectional survey design. 86 valid responses were assessed using an online structured questionnaire; 84% of respondents had...
Published on: Fri, 12 Jun 2026 06:00:00 -0400
Authors: Joyce Joseph, Harshhni Vummiti Lakshminarayana,
Intermittent fasting (IF) has emerged as a popular dietary intervention with potential metabolic and endocrine benefits. However, its effects on sexual function and reproductive health remain incompletely understood. This comprehensive review synthesizes current evidence from human clinical trials and animal studies examining the impact of various IF protocols-including time-restricted eating (TRE), alternate-day fasting (ADF), and Ramadan fasting-on male and female sexual function, reproductive...
Published on: Fri, 12 Jun 2026 06:00:00 -0400
Authors: Sandro La Vignera, Rosita A Condorelli,
Ovarian function is critically dependent on tightly coordinated cellular energy metabolism, which governs follicular development, oocyte competence, and reproductive longevity. Increasing evidence indicates that metabolic dysregulation, including mitochondrial dysfunction, oxidative imbalance, and impaired NAD^(+) metabolism, contributes to the pathophysiology of major ovarian disorders such as PCOS, ovarian aging, and DOR. In parallel, emerging studies suggest that nutritional factors influence...
Published on: Fri, 12 Jun 2026 06:00:00 -0400
Authors: Jihyun Kim, Jaewang Lee,
Incretin-based therapies, particularly glucagon-like peptide-1 receptor agonists (GLP-1 RAs), have emerged as potentially promising therapeutic agents for improving ovarian function, especially in women with polycystic ovary syndrome (PCOS) and obesity-related reproductive dysfunction. This comprehensive review synthesizes evidence from 30 highly relevant studies examining the mechanisms of action, clinical outcomes, and safety profile of incretin therapies on ovarian function. The evidence...
Published on: Fri, 12 Jun 2026 06:00:00 -0400
Authors: Sandro La Vignera, Rosita A Condorelli,
Polycystic ovary syndrome (PCOS) is one of the most common metabolic-endocrine disorders affecting women of reproductive age and represents a significant public health concern due to its clinical heterogeneity. It is characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology, and is frequently associated with hyperinsulinemia, obesity, dyslipidemia, chronic low-grade inflammation, and an increased risk of type 2 diabetes and cardiovascular disease. Conventional...
Published on: Fri, 12 Jun 2026 06:00:00 -0400
Authors: Rosa Linares, Gabriela Rosas, Elizabeth Vieyra, Andrea Chaparro, Julieta-Azucena Espinoza, Deyra de Los Angeles Ramírez, Carlos-Camilo Silva, Patricia Rosas, Víctor-Manuel Macías, Leticia Morales-Ledesma,
Polycystic ovary syndrome (PCOS) is a complex endocrine-metabolic disorder characterized by hyperandrogenism, chronic anovulation, and insulin resistance, with hyperinsulinemia playing a pivotal role in exacerbating ovarian dysfunction. Although berberine (BBR) exhibits insulin-sensitizing properties, its therapeutic potential is limited by poor oral bioavailability. Our previous study developed BBR cocrystals with gallic and gentisic acid, achieving a 1.8-fold increase in C(max) to overcome...
Published on: Thu, 11 Jun 2026 06:00:00 -0400
Authors: Umanath Kamalakannan, Anuja Venkata Sai Durga Surampudi, Vyshnavi Racha, Ramars Amanchy, Nishant Jain, Kathirvel Muralidharan,
Infertility is an increasing concern for many women and can affect both physical and emotional well-being. The central nervous system (CNS) -particularly the hypothalamus, pituitary gland, and pineal gland - plays a crucial role in female reproductive health. We conducted a narrative review of relevant studies published between 2015 and 2025, sourcing data from PubMed and Scopus. Our goal was to investigate how dysregulation of hormones from the hypothalamus, pituitary gland, and pineal gland...
Published on: Thu, 11 Jun 2026 06:00:00 -0400
Authors: Amirreza Shakoeizadeh, Erfan Shahabinejad, Mahdi Heydari, Amirmohammad Shahidzadeh, Soheila Pourmasumi,
CONCLUSION: The HMGB1-TLR4-INF-β signaling axis appears to contribute to low-grade inflammation in PCOS. The soluble form of TLR4 may act as a regulatory modulator that attenuates inflammatory signaling. The integration of biochemical and computational data findings provides novel insights into immune-metabolic dysregulation in PCOS and highlights potential therapeutic targets for modulating inflammation.
Published on: Thu, 11 Jun 2026 06:00:00 -0400
Authors: Ahmed Kareem Atheeb, Saba Zuhair Hussein,
CONCLUSIONS: This article summarises the therapeutic approaches targeting insulin resistance and the enhancement of endometrial receptivity based on the above pathways, so as to provide references and suggestions for future therapeutic strategies.
Published on: Thu, 11 Jun 2026 06:00:00 -0400
Authors: Si-Yan Huang, Shao-Rong Chen, Wei-Hong Chen, Ling-Tao Zheng, Jing Xu, Yan-Chuan Shi, Shu Lin, Qi-Rong Shi,
Juvenile hemochromatosis (JH) is a rare disorder caused by iron metabolism errors that lead to severe iron loading and organ failure in young adults before 30 years of age. We report a challenging case of a 26-year-old female whose diagnosis was delayed by nearly a decade due to deceptively nonspecific symptoms. She initially presented with oligomenorrhea at age 18 and was misdiagnosed with polycystic ovary syndrome (PCOS). Subsequent work-up for primary infertility revealed idiopathic...
Published on: Thu, 11 Jun 2026 06:00:00 -0400
Authors: Purnima Agarwal, Ambrish Mithal, Komarakshi Balakrishnan, Murali Krishna Tanguturu, Suresh Rao Kemundel Genny,
CONCLUSIONS: This case is attributed to a de novo p.Asp1110His variant in INSR. The diagnostic process highlights the importance of genetic testing in adolescents presenting with atypical PCOS features, particularly severe hyperinsulinemia and non-obesity. This report expands the known pathogenic variant spectrum of the INSR gene and reviews TAIRS cases reported since 2010. It further emphasizes that long-term management of TAIRS requires individualized, multidisciplinary strategies, including...
Published on: Thu, 11 Jun 2026 06:00:00 -0400
Authors: Chunmin Ji, Xiaojun Zheng, Quanxing Wang, Zhongyun Chen,
Background Combined oral contraceptives (COCs) are the cornerstone therapy for polycystic ovary syndrome (PCOS). While COCs have been shown to improve cognitive performance, the relationship between these gains and hormonal profiles, especially testosterone, remains unclear. This study investigated whether baseline testosterone levels correlate with cognitive changes after COC treatment. Methods This quasi-experimental study evaluated 35 nulliparous women (aged 18-35 years) with PCOS. Baseline...
Published on: Thu, 11 Jun 2026 06:00:00 -0400
Authors: Saloni Kumari, Sheeba Marwah, Soumen Manna, Himani Ahluwalia,
The present study investigated the role of melatonin (MT) in regulating mitochondrial function via sirtuin 3 (SIRT3) in granulosa cells (GCs) from patients with polycystic ovary syndrome (PCOS), with a focus on mitochondrial protection. Notably, GCs isolated from patients with PCOS exhibited mitochondrial dysfunction. Using an in vitro PCOS model established by treating KGN cells with dihydrotestosterone (DHT), decreased SIRT3 expression, dysregulated mitochondrial dynamics and hyperactivation...
Published on: Thu, 11 Jun 2026 06:00:00 -0400
Authors: Congcong Xie, Zehao Liu, Tong Chen, Hui Lu, Xiujia Zhang, Wenbo Yu, Jiaxin Zhang, Dandan Shang, Xueying Wang,
BACKGROUND: Emerging concepts on the role of insulin resistance (IR) in the pathogenesis of polycystic ovary syndrome (PCOS) have driven a shift in the therapeutic approach towards interventions targeting IR. SarogLItazar as an add-on to Metformin in PolyCystic Ovary Syndrome (SLIM-PCOS) trial aims to test the efficacy and safety of saroglitazar, a dual peroxisome proliferator-activated receptor (PPAR α/γ) agonist belonging to "glitazar" class of drugs, on top of metformin and lifestyle...
Published on: Thu, 11 Jun 2026 06:00:00 -0400
Authors: Niti Mittal, Savita Singhal, Rakesh Mittal,
Extracellular vesicles (EVs), particularly exosomes, are small membrane-bound vesicles that mediate intercellular communication by transferring bioactive molecules such as proteins, lipids, and nucleic acids. Increasing evidence highlights their critical role in maintaining physiological homeostasis and in the pathogenesis of multiple diseases. In the context of women's health, exosomes have emerged as key regulators of reproductive function, endocrine signaling, immune modulation, and hormonal...
Published on: Wed, 10 Jun 2026 06:00:00 -0400
Authors: Vibhuti Agrahari, Dimple Modi, Masumi Dave, Lipika Chablani,